Pain Management and Opioids: Balancing Risks and Benefits - Winfield, IL - Saturday, October 12, 2019

5 (1 vote)

image

Host: Illinois Society of Addiction Medicine

Date:Saturday October 12, 2019 | 8:00 am – 11:00 am

Location: Northwestern Medicine Central DuPage Hospital

Cost: FREE

The misuse of opioids is a major public health problem. Centers for Disease Control and Prevention reported the following:

  • From 1999 to 2016 more than 630,000 people died from drug overdoses.
  • 115 Americans die every day from an opioid overdose.

The CO*RE/ASAM Pain Management and Opioids: Balancing Risks and Benefits curriculum is newly updated to reflect the latest information in this vital area of healthcare. The thoroughly revised curriculum addresses: the nature and pathophysiology of pain; assessing patients in pain; creating a pain treatment plan; initiating opioid therapy; managing patients on opioid analgesics; educating patients and caregivers; and understanding opioid use disorder. This program meets many states requirements for opioid education and is fully compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) education requirement (“Blue Print”), issued by the U.S. Food & Drug Administration in September 2018. 

Edwin A. Salsitz

MD, DFASAM

Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel , Division of Chemical Dependency, New York City, since 1983, and is an Assistant Professor of Psychiatry at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. 

Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.Dr. Salsitz is a course director for ASAM sponsored buprenorphine trainings,and is a mentor in the PCSS-MAT mentoring program. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. 

Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee. Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.  Dr. Salsitz is the recipient of the 2014 ASAM Annual Award, and the 2018 ASAM Annual Educator of the Year Award.

David Lott

MD

Dr. Lott specializes in Addiction treatment in the Chicago area and is a Clinical Associate Professor of Psychiatry at the University of Illinois College of Medicine in Chicago.  He is a Distinguished Fellow of the American Society of Addiction Medicine and the American Psychiatric Association.  In addition, he currently serves as a Board member and President-Elect of the Illinois Society of Addiction Medicine.

Dr. Lott received his undergraduate degree from Duke University and completed medical school at Johns Hopkins University.  He returned to Chicago for a residency in Psychiatry at The University of Chicago and a fellowship in Addiction Psychiatry at The University of Illinois at Chicago.  He is board certified in Psychiatry, Addiction Psychiatry and Addiction Medicine.

Dr. Lott previously led the Addictions Services at Linden Oaks Hospital, part of the Edward-Elmhurst Healthcare system in the western suburbs of Chicago, from 2005 through 2017, where he helped in development of a variety of addiction focused programs. He has published several peer-reviewed articles in the addiction field, remains active in teaching, and provides buprenorphine waiver trainings through ASAM as well as PCSS.

Ernest C. Rose

MD

A graduate of University of Louisville School of Medicine, Dr. Ernest C. Rose completed residency in Anesthesiology, Critical Care, and Pain Management at the University of Iowa. He practiced anesthesia and Pain Management from 1979 through 1996. Dr. Rose transitioned to an exclusive practice of Addiction Medicine in 1997. His practice has covered the field from Levels I through IV.

Dr.  Rose’s current practice includes Medical Director of multiple facilities  and CEO / Medical Director of Rose Medical Association, Inc . in Peoria IL (methadone maintenance, Level-I, Level-II & DUI) & Rose Medical Association, Inc. in Springfield, IL.

He’s been a Medical Review Officer since 2001, ASAM certified since 2002, and ABAM certified since 2014 and has achieved status as Fellow of the American Society of Addiction Medicine (FASAM). He is a practicing physician and currently serves as President of the Illinois chapter of ASAM (ISAM).

CME Information and Disclosure Listing

The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. ASAM has been awarded the highest level of Accreditation with Commendation by the ACCME as a provider of continuing medical education.  

The American Society of Addiction Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

In accordance with the disclosure policies of the American Society of Addiction Medicine (ASAM) and the Accreditation Council for Continuing Medical Education (ACCME), the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between the Medical Education Council, the CME Committee, program planning committees and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of the activity. All program planning committee members and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The ASAM CME Committee has reviewed these disclosures and determined that the program planning committee and faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.  

ASAM CME Committee

Name

Commercial Interest

What was received?

For what role?

Catherine R. Friedman, MD, FAPA, DFASAM, Chair

None

 

 

R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM

None

 

 

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO

None

 

 

Zwaantje Hamming, FNP-C, CARN-AP

None

 

 

Noel Ilogu, MD, MRCP, DFASAM

None

 

 

Hebert L. Malinoff, MD, FACP, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

ASAM Staff and Consultants:

 

 

 

Arlene C. Deverman, MA, CAE, CFRE

None

 

 

Marcia Jackson PhD

None

 

 

Sandy Metcalfe

None

 

 

Program Planning Committee

Name

Commercial Interest

What was received?

For what role?

Herbert Malinoff, MD, FACP, DFASAM

None

 

 

Yngvild Olsen, MD, MPH

None

 

 

Theodore Parran, MD, FACP

None

 

 

Edwin Salsitz, MD, DFASAM

None

 

 

R. Corey Waller, MD, MS, FACEP

None

 

 

Faculty

Name

Commercial Interest

What was received?

For what role?

Kirk Moberg, MD, FASAM

None

 

 

ASAM CME Committee Reviewers

Name

Commercial Interest

What was received?

For what role?

Jacob Bobrowski, MD, FAAFP

None

 

 

Anthony H. Dekker, DO, DFASAM

None

 

 

ASAM Medical Education Council

Name

Commercial Interest

What was received?

For what role?

Peter Selby, MBBS, CCFP, FCFP, MHSc, DipABAM, DFASAM, Chair

Pfizer

Johnson & Johnson

Pfizer Canada

Grant funding

Consulting Fees

Consulting Fees

 Principal Investigator

Consulting

Consulting

Daniel Alford, MD, MPH

None

 

 

Michael Fingerhood, MD, FACP, FASAM

None

 

 

Catherine R. Friedman, MD, FAPA, DFASAM

None

 

 

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO

None

 

  

Miriam S. Komaromy, MD, FACP, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Mark P. Schwartz, MD, DFASAM

None

 

 

Mark A. Weiner, MD, FASAM

None

 

 

ASAM Staff and Consultants:

 

 

 

Arlene C. Deverman, MA, CAE, CFRE

None

 

 

Marcia Jackson PhD

None

 

 

Jennifer L. Butchart

None

 

 

Penny S. Mills, MBA

None

 

 

 

Central DuPage Hospital
Inpatient Pavilion Entrance
Bed Tower – Auditorium
25 N. Winfield Rd, Winfield, IL

Park in Lots 3, 4, 5 and 6. Allow plenty of time for parking. 

Key:

Complete
Failed
Available
Locked
Live In-Person Course - Saturday, October 12, 2019
10/12/2019 at 8:00 AM (EDT)   |  180 minutes
10/12/2019 at 8:00 AM (EDT)   |  180 minutes